Unlimited access to the most powerful analytical tools in finance.

Subscribe for $2
Overview
Profile
Huadong Medicine Co Stock

Huadong Medicine Co Stock 000963.SZ

000963.SZ
CNE0000011S1

Price

40.09
Today +/-
-0.05
Today %
-1.07 %

Huadong Medicine Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Huadong Medicine Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Huadong Medicine Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Huadong Medicine Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Huadong Medicine Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Huadong Medicine Co Stock Price History

DateHuadong Medicine Co Price
6/26/202540.09 undefined
6/25/202540.52 undefined
6/24/202540.23 undefined
6/23/202539.84 undefined
6/20/202541.48 undefined
6/19/202541.26 undefined
6/18/202541.40 undefined
6/17/202541.94 undefined
6/16/202543.68 undefined
6/13/202544.52 undefined
6/12/202545.07 undefined
6/11/202543.54 undefined
6/10/202543.73 undefined
6/9/202543.81 undefined
6/6/202543.08 undefined
6/5/202543.71 undefined
6/4/202544.61 undefined
6/3/202544.52 undefined
5/30/202544.90 undefined
5/29/202543.36 undefined
5/28/202542.52 undefined

Huadong Medicine Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Huadong Medicine Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Huadong Medicine Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Huadong Medicine Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Huadong Medicine Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Huadong Medicine Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Huadong Medicine Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Huadong Medicine Co’s growth potential.

Huadong Medicine Co Revenue, EBIT and net profit per share

DateHuadong Medicine Co RevenueHuadong Medicine Co EBITHuadong Medicine Co Net Income
2027e52.1 B undefined6.15 B undefined5.33 B undefined
2026e48.67 B undefined5.56 B undefined4.39 B undefined
2025e45.35 B undefined4.92 B undefined3.82 B undefined
202441.91 B undefined4.43 B undefined3.51 B undefined
202340.62 B undefined3.67 B undefined2.84 B undefined
202237.71 B undefined3.19 B undefined2.5 B undefined
202134.56 B undefined2.9 B undefined2.3 B undefined
202033.68 B undefined3.17 B undefined2.82 B undefined
201935.45 B undefined3.33 B undefined2.81 B undefined
201830.66 B undefined2.93 B undefined2.27 B undefined
201727.83 B undefined2.37 B undefined1.78 B undefined
201625.38 B undefined1.89 B undefined1.45 B undefined
201521.73 B undefined1.55 B undefined1.1 B undefined
201418.95 B undefined1.27 B undefined757 M undefined
201316.72 B undefined1.02 B undefined575 M undefined
201214.58 B undefined889 M undefined470 M undefined
201111.13 B undefined690 M undefined381 M undefined
20108.97 B undefined502 M undefined317 M undefined
20097.83 B undefined574 M undefined379 M undefined
20086.02 B undefined360 M undefined189 M undefined
20074.85 B undefined358 M undefined173 M undefined
20063.97 B undefined213 M undefined97 M undefined
20053.48 B undefined173 M undefined67 M undefined

Huadong Medicine Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B)
NET INCOME (B)
NET INCOME GROWTH (%)
DIV. ()
DIV. GROWTH (%)
SHARES (B)
DOCUMENTS
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
1.621.892.072.332.883.483.974.856.027.838.9711.1314.5816.7218.9521.7325.3827.8330.6635.4533.6834.5637.7140.6241.9145.3548.6752.1
-16.569.5412.5823.9020.8913.8922.3023.9630.0714.6624.0630.9814.6713.3314.6716.819.6610.1715.60-4.972.619.127.713.168.237.307.05
16.6916.0115.0016.2916.9317.8819.7121.0019.1319.4818.5019.2119.5120.1721.9623.9724.2726.1228.9832.0633.0430.6531.8932.3833.1730.6528.5626.68
0.270.30.310.380.490.620.781.021.151.521.662.142.853.374.165.216.167.278.8911.3611.1310.5912.0313.1613.9000
0.050.050.050.030.030.070.10.170.190.380.320.380.470.580.761.11.451.782.272.812.822.32.52.843.513.824.395.33
-20.00-12.96-34.04-116.1344.7878.359.25100.53-16.3620.1923.3622.3431.6544.9131.9123.0127.3624.080.25-18.408.6013.5723.758.8614.9421.30
----------------------------
----------------------------
1.371.371.371.371.371.371.391.561.561.561.561.561.561.561.561.561.741.751.751.751.751.751.751.751.75000
----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Huadong Medicine Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Huadong Medicine Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (B)
RECEIVABLES (B)
OTHER REC. (B)
INVENTORIES (B)
OTHER CURRENT LIAB. (B)
CURRENT ASSETS (B)
TANGIBLE ASSETS (B)
LONG-T. INVEST. (B)
LONG-T. REC. (M)
INTANGIBLE ASSETS (B)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (B)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (B)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (B)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (B)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (B)
SHORT-TERM DEBTS (B)
LONG-TERM DEBT PORTION (B)
SHORT-TERM REC. (B)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212021202220232024
                                                   
0.310.350.320.320.430.580.350.490.480.570.330.780.770.851.011.492.662.512.42.233.164.033.583.454.224.99
0.290.310.330.320.40.420.470.50.781.271.522.282.673.13.644.474.895.636.096.146.946.437.27.468.43
0.050.020.030.020.020.040.090.190.230.190.390.630.430.590.781.081.031.070.750.840.970.220.771.351.782.14
0.250.270.330.350.430.490.760.80.910.730.991.11.531.721.822.423.083.413.884.044.073.973.974.54.294.78
0.060.080.030.060.060.080.070.110.10.140.180.20.150.210.260.330.470.930.410.540.330.590.731.080.750.72
0.961.031.041.071.341.611.742.092.492.893.394.715.166.036.978.9611.7112.7913.0713.7414.6615.7615.4917.5718.521.05
0.130.160.240.260.310.310.290.290.410.430.610.7611.171.461.821.982.222.834.184.714.814.865.075.295.49
0.040.040.040.060.080.080.040.050.050.060.060.080.090.090.140.160.170.190.20.491.091.241.262.032.112.16
000000000000000000000223.920284.1400
0.020.010.050.050.040.060.070.060.070.120.170.260.240.320.290.380.490.611.511.461.462.232.232.923.334.68
000000000000.010.010.010.010.020.010.041.461.471.472.142.142.442.62.91
0000.01000.020.010.010.020.020.030.040.060.130.090.10.130.160.140.810.931.021.161.691.59
0.190.210.340.370.430.450.420.410.550.630.861.141.381.652.042.462.753.196.157.739.5511.5811.5113.9115.0116.83
1.141.241.371.441.772.052.172.53.043.514.265.846.547.679.0111.4214.4615.9919.2221.4724.227.342731.4833.5137.88
                                                   
0.190.190.380.380.380.380.430.430.430.430.430.430.430.430.430.430.490.971.461.751.751.751.751.751.751.75
0.260.260.110.110.110.110.060.060.010.010.010.010.010.010.010.023.442.942.462.162.162.232.232.382.452.55
0.030.080.080.090.090.12-0.010.090.250.640.721.091.562.131.822.523.364.486.058.3810.7112.6512.6514.6416.9718.85
000000000000000000-2223-2314.18-56.51-90.47-48.75-52.33
000-1-2-70000000000000008.748.741.928.411.73
0.480.530.570.580.580.610.480.580.71.081.161.5322.572.272.977.288.399.9412.3114.6216.9516.5818.6821.1323.11
0.230.240.270.270.350.420.460.610.781.011.381.732.032.262.472.83.353.453.913.793.954.523.854.874.374.47
51649065691071041001391601953394168174208367451518475540920.63934.97535.23569.97671.81
0.040.040.020.030.040.050.140.160.280.220.120.330.30.361.30.791.11.461.781.842.141.961.952.272.773.14
0.30.320.360.430.660.780.890.950.950.831.171.871.671.772.3230.940.751.191.271.971.632.32.372.925.24
000000000.030.030.030000.020.060.03001.030.040.240.240.110.160.28
0.630.670.740.81.121.361.591.812.182.252.93.974.094.556.286.855.786.117.48.48.639.279.2710.1510.813.79
000000000000.070.10.10.191.31.010.99100.150.220.221.140.580.09
000000000000000000204089184.91184.91202.08184.37197.38
60000581016279761118232273378161148-1,604.89384.51524.8362.66237.56
0.0100000.010.010.010.020.030.010.080.10.110.211.321.031.071.390.20.39-1.20.791.861.120.52
0.630.670.740.81.121.371.61.822.22.282.914.054.24.666.498.176.827.188.798.69.028.0710.0612.0211.9314.32
1.111.21.311.371.71.972.082.42.93.354.075.586.27.238.7611.1414.0915.5718.7320.9123.6425.0226.6330.733.0637.42
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Huadong Medicine Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Huadong Medicine Co's financial health and stability.

Assets

Huadong Medicine Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Huadong Medicine Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Huadong Medicine Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Huadong Medicine Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (B)
NET CASH FLOW FROM OPERATING ACTIVITIES (B)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (B)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (B)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120212022
000000000000000000002.302.5
000000000000000000005910698
00000000000000000000000
-96-151-174-258-327-449-443-574-626-1,000-1,132-1,783-2,141-2,666-3,366-3,860-4,585-5,859-7,598-7,20835-7,415-8,133
00000000000000000000000
00000000000000000000000
-0.09-0.11-0.1-0.14-0.17-0.19-0.24-0.27-0.36-0.39-0.49-0.72-0.75-1.04-1.26-1.32-1.63-1.97-2.12-2.171.54-1.54-3.02
0.110.020.090.010.20.070.270.340.57-0.030.020.640.480.740.661.351.662.0423.413.173.172.38
-53-56-73-66-50-83-32-88-129-170-224-257-335-324-383-467-478-876-1,353-1,473-819-819-1,193
64-57-74-13215-154-35-154-106-41-265-239-327-814-819-613-1,006-1,560-1,582-1,738-1,986-1,986-2,435
117-1-1-6565-70-2-6623129-40178-489-436-146-527-684-229-265-1,167-1,167-1,242
00000000000000000000000
0.020.030.040.220.05-00.06-0.08-0.270.190.88-0.230.160.61.5-2.26-0.160.070.03-0.06-0.15-0.190.4
0000000000000000000000104
-324-12151-33-144-103-176-349-183664-402-31208628457-912-430-608-725-767-767-99
00000-0.01-00.020.010-0.040.03-0.070.04-0.343.42-0.020.27-0.07-0.1-0.16-0.120.08
-51-27-59-68-79-128-154-114-93-379-175-206-121-427-529-697-727-769-570-565-460-460-576
0.440.250.360.440.880.471.071.21.671.112.053.143.494.595.757.727.619.8911.5513.7112.5412.5513.37
56.5-32.617.3-54.1153.3-15.1233.5256.5438.6-198.9-208.1385.7141.2416275.58801,182.41,163648.31,938.42,350.662,350.661,188.61
00000000000000000000000

Huadong Medicine Co stock margins

The Huadong Medicine Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Huadong Medicine Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Huadong Medicine Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Huadong Medicine Co's sales revenue. A higher gross margin percentage indicates that the Huadong Medicine Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Huadong Medicine Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Huadong Medicine Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Huadong Medicine Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Huadong Medicine Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Huadong Medicine Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Huadong Medicine Co Margin History

Huadong Medicine Co Gross marginHuadong Medicine Co Profit marginHuadong Medicine Co EBIT marginHuadong Medicine Co Profit margin
2027e33.17 %11.81 %10.23 %
2026e33.17 %11.42 %9.03 %
2025e33.17 %10.84 %8.43 %
202433.17 %10.58 %8.38 %
202332.38 %9.04 %6.99 %
202231.89 %8.46 %6.63 %
202130.65 %8.4 %6.66 %
202033.04 %9.4 %8.37 %
201932.06 %9.39 %7.94 %
201828.98 %9.57 %7.39 %
201726.12 %8.5 %6.4 %
201624.27 %7.46 %5.7 %
201523.97 %7.13 %5.05 %
201421.96 %6.71 %4 %
201320.17 %6.08 %3.44 %
201219.51 %6.1 %3.22 %
201119.21 %6.2 %3.42 %
201018.5 %5.6 %3.53 %
200919.48 %7.34 %4.84 %
200819.13 %5.98 %3.14 %
200721 %7.38 %3.56 %
200619.71 %5.37 %2.44 %
200517.88 %4.97 %1.92 %

Huadong Medicine Co Stock Sales Revenue, EBIT, Earnings per Share

The Huadong Medicine Co earnings per share therefore indicates how much revenue Huadong Medicine Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Huadong Medicine Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Huadong Medicine Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Huadong Medicine Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Huadong Medicine Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Huadong Medicine Co Revenue, EBIT and net profit per share

DateHuadong Medicine Co Sales per ShareHuadong Medicine Co EBIT per shareHuadong Medicine Co Earnings per Share
2027e29.72 undefined0 undefined3.04 undefined
2026e27.76 undefined0 undefined2.51 undefined
2025e25.87 undefined0 undefined2.18 undefined
202423.9 undefined2.53 undefined2 undefined
202323.22 undefined2.1 undefined1.62 undefined
202221.55 undefined1.82 undefined1.43 undefined
202119.75 undefined1.66 undefined1.32 undefined
202019.25 undefined1.81 undefined1.61 undefined
201920.25 undefined1.9 undefined1.61 undefined
201817.52 undefined1.68 undefined1.3 undefined
201715.9 undefined1.35 undefined1.02 undefined
201614.62 undefined1.09 undefined0.83 undefined
201513.9 undefined0.99 undefined0.7 undefined
201412.12 undefined0.81 undefined0.48 undefined
201310.7 undefined0.65 undefined0.37 undefined
20129.33 undefined0.57 undefined0.3 undefined
20117.12 undefined0.44 undefined0.24 undefined
20105.74 undefined0.32 undefined0.2 undefined
20095.01 undefined0.37 undefined0.24 undefined
20083.85 undefined0.23 undefined0.12 undefined
20073.1 undefined0.23 undefined0.11 undefined
20062.85 undefined0.15 undefined0.07 undefined
20052.55 undefined0.13 undefined0.05 undefined

Huadong Medicine Co business model

Huadong Medicine Co Ltd is a leading pharmaceutical company headquartered in Hangzhou, China. It was founded in 1989 and has since become one of the most significant players in the research, development, production, and distribution of medical products in China. History In its early years, the company started as a manufacturer of simple pharmaceutical products, namely painkillers and dermatological products. However, Huadong Medicine soon focused on the production of innovative medications and equipped itself with modern technological facilities and processes. Today, the company specializes in this field and tirelessly works on the development and production of high-quality medications and medical devices. Business Model Huadong Medicine operates according to a holistic business model that focuses on the well-being of people. To achieve this, the company combines research, development, and production, allowing it to offer innovative solutions for various patient needs. Additionally, the company emphasizes the rapid market introduction of new products and the efficient marketing of its offerings. Segments Huadong Medicine operates in several different segments, including: - Pharmaceutical Products - Medical Devices and Equipment - Medical Foods The pharmaceutical products comprise the development and production of medicines such as antibiotics, painkillers, vitamins, as well as treatments for hypertension, diabetes, and cancer. Medical devices and equipment are used to provide healthcare services, including disposable and reusable needles, syringes, and surgical instruments. Medical foods include dietary supplements and technologies for producing foods with functional properties. Products Huadong Medicine offers a wide range of products that meet the needs of people in different parts of the world. These include: - Antibiotics such as Amoxicillin and Clavulanic Acid - Painkillers such as Ibuprofen and Paracetamol - Vitamins such as Vitamin C, B1, B2, and B5, as well as multivitamins - Hypertension treatments such as Telmisartan and Ramipril - Diabetes treatments such as Metformin and Glibenclamide - Cancer treatments such as Paclitaxel and Zoledronic Acid - Disposable and reusable needles and surgical instruments - Dietary supplements such as Ginseng Extract and Glucosamine Conclusion Huadong Medicine is a company that is committed to helping people with its products. Over the years, the company has worked hard to improve its performance in the areas of research, development, production, and distribution of medical products. Today, it takes pride in being one of the top companies in the field of medical products and solutions in China. Huadong Medicine Co is one of the most popular companies on Eulerpool.com.

Huadong Medicine Co SWOT Analysis

Strengths

  • Strong market presence and brand reputation in the pharmaceutical industry.
  • Broad product portfolio with a diverse range of medicines and healthcare products.
  • Robust distribution network that enables wide reach and access to customers.

Weaknesses

  • Dependence on third-party suppliers for raw materials and ingredients, which may pose potential supply chain risks.
  • Limited geographic diversification, primarily focused on the domestic Chinese market.
  • Relatively lower investment in research and development compared to some competitors.

Opportunities

  • Increasing demand for innovative healthcare solutions, providing opportunities for new product development and market expansion.
  • Growing aging population and rising healthcare expenditure in China, creating a larger customer base for pharmaceutical products.
  • Potential for strategic partnerships and collaborations, especially in exploring digital health and technology-driven solutions.

Threats

  • Intense competition from both domestic and international pharmaceutical companies.
  • Regulatory changes and governmental policies affecting the pharmaceutical industry.
  • Potential disruptions in the supply chain due to global events or economic uncertainties.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Huadong Medicine Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Huadong Medicine Co historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Huadong Medicine Co shares outstanding

The number of shares was Huadong Medicine Co in 2024 — This indicates how many shares 1.753 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Huadong Medicine Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Huadong Medicine Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Huadong Medicine Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Huadong Medicine Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Huadong Medicine Co stock splits

In Huadong Medicine Co's history, there have been no stock splits.

Huadong Medicine Co dividend history and estimates

In 2024, Huadong Medicine Co paid a dividend amounting to 0.93 CNY. Dividend means that Huadong Medicine Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Huadong Medicine Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Huadong Medicine Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Huadong Medicine Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Huadong Medicine Co Dividend History

DateHuadong Medicine Co Dividend
2027e1.03 undefined
2026e1.03 undefined
2025e1.03 undefined
20240.93 undefined
20230.29 undefined
20220.29 undefined
20210.23 undefined
20200.28 undefined
20190.28 undefined
20180.4 undefined
20170.38 undefined
20160.35 undefined
20150.26 undefined
20140.19 undefined
20100.18 undefined
20070.04 undefined
20060.04 undefined
20050.03 undefined

Huadong Medicine Co dividend payout ratio

In 2024, Huadong Medicine Co had a payout ratio of 18.73%. The payout ratio indicates the percentage of the company's profits that Huadong Medicine Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Huadong Medicine Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Huadong Medicine Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Huadong Medicine Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Huadong Medicine Co Payout Ratio History

DateHuadong Medicine Co Payout ratio
2027e18.87 %
2026e18.75 %
2025e19.14 %
202418.73 %
202318.39 %
202220.3 %
202117.49 %
202017.39 %
201917.08 %
201830.77 %
201736.76 %
201641.83 %
201536.51 %
201440.51 %
201318.39 %
201218.39 %
201118.39 %
201091.67 %
200918.39 %
200818.39 %
200740.4 %
200653.57 %
200555.56 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Huadong Medicine Co.

Huadong Medicine Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20250.52 0.52  (-0.04 %)2025 Q1
12/31/20240.43 0.54  (25.79 %)2024 Q4
9/30/20240.48 0.5  (2.53 %)2024 Q3
6/30/20240.45 0.48  (5.03 %)2024 Q2
3/31/20240.47 0.49  (5.57 %)2024 Q1
12/31/20230.36 0.37  (1.4 %)2023 Q4
9/30/20230.41 0.43  (5.28 %)2023 Q3
6/30/20230.39 0.39  (-0.05 %)2023 Q2
3/31/20230.46 0.43  (-7.23 %)2023 Q1
12/31/20220.31 0.3  (-2.98 %)2022 Q4
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the Huadong Medicine Co stock

Eulerpool World ESG Rating (EESG©)

75/ 100

🌱 Environment

68

👫 Social

77

🏛️ Governance

80

Environment

Scope 1 - Direct Emissions
14,288.85
Scope 2 - Indirect emissions from purchased energy
137,814.6
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
152,103.45
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees48.29
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Huadong Medicine Co shareholders

%
Name
Stocks
Change
Date
41.69470 % China Grand Enterprises, Inc.730,938,15709/30/2024
16.42830 % Hangzhou Huadong Medicine Group Co., Ltd.288,000,00009/30/2024
1.42143 % E Fund Management Co. Ltd.24,918,76411,703,5329/30/2024
0.98893 % Harvest Fund Management Co., Ltd.17,336,71510,242,7859/30/2024
0.98444 % Huatai-PineBridge Fund Management Co., Ltd.17,257,9456,691,3009/30/2024
0.81243 % Zhong Ou Asset Management Co., Ltd.14,242,403957,2499/30/2024
0.62653 % China Merchants Fund Management Co. Ltd.10,983,60409/30/2024
0.57043 % ICBC Credit Suisse Asset Management Co. Ltd.10,000,000-2,000,0009/30/2024
0.51822 % Norges Bank Investment Management (NBIM)9,084,821473,25712/31/2024
0.49348 % China Asset Management Co., Ltd.8,651,030811,1306/30/2024
1
2
3
4
5
...
10

Huadong Medicine Co Executives and Management Board

Mr. Liang Lu

(49)
Huadong Medicine Co Chairman of the Board, General Manager (since 2010)
Compensation 2.4 M

Mr. Hui Wu

(55)
Huadong Medicine Co Deputy General Manager
Compensation 1.4 M

Mr. Jianfei Zhang

(49)
Huadong Medicine Co Deputy General Manager
Compensation 1.4 M

Ms. Li Zhu

(49)
Huadong Medicine Co Deputy General Manager
Compensation 1.4 M

Mr. Renbo Qiu

(42)
Huadong Medicine Co Finance Director
Compensation 1.3 M
1
2
3

Huadong Medicine Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Exscientia ADR Stock
Exscientia ADR
SupplierCustomer0,89-0,120,090,48
vTv Therapeutics A Stock
vTv Therapeutics A
SupplierCustomer0,77-0,62-0,150,210,49-0,03
Kiniksa Pharmaceuticals A Stock
Kiniksa Pharmaceuticals A
SupplierCustomer0,62-0,43-0,150,180,54-0,47
Jetema Stock
Jetema
SupplierCustomer0,33-0,65-0,24-0,200,420,48
Guizhou Xinbang Pharm A Stock
Guizhou Xinbang Pharm A
SupplierCustomer-0,200,430,230,630,600,64
Innovate Stock
Innovate
SupplierCustomer-0,27-0,63-0,090,340,180,62
Provention Bio Stock
Provention Bio
SupplierCustomer-0,37-0,50 -0,320,22-0,60
ImmunoGen Stock
ImmunoGen
SupplierCustomer-0,60-0,660,080,340,290,20
Shanghai Medicilon A Stock
Shanghai Medicilon A
SupplierCustomer-0,67-0,04-0,130,07-0,260,52
Grand Pharmaceutical Group Stock
Grand Pharmaceutical Group
SupplierCustomer-0,89-0,610,450,610,660,17
1

Most common questions regarding Huadong Medicine Co

What values and corporate philosophy does Huadong Medicine Co represent?

Huadong Medicine Co Ltd represents values of integrity, innovation, and excellence. With a strong corporate philosophy focused on delivering high-quality pharmaceutical products and providing comprehensive healthcare solutions, Huadong Medicine Co Ltd aims to improve the well-being of people globally. The company's commitment to research and development, stringent quality control, and ethical business practices sets it apart in the industry. Huadong Medicine Co Ltd undertakes extensive efforts to meet customer needs, advance medical knowledge, and contribute to the advancement of healthcare. As an industry leader, Huadong Medicine Co Ltd consistently upholds its core values to foster growth and create sustainable value for its stakeholders.

In which countries and regions is Huadong Medicine Co primarily present?

Huadong Medicine Co Ltd is primarily present in China and its surrounding regions.

What significant milestones has the company Huadong Medicine Co achieved?

Huadong Medicine Co Ltd has achieved significant milestones since its establishment. The company has successfully expanded its presence in the pharmaceutical industry and has become a leading player in the Chinese market. Huadong Medicine Co Ltd has witnessed continuous growth in revenue and market capitalization, reflecting its successful business strategies and strong financial performance. Additionally, the company has made notable advancements in research and development, launching innovative and high-quality pharmaceutical products that have gained recognition both domestically and internationally. Huadong Medicine Co Ltd has also established strategic partnerships and collaborations, further enhancing its competitive position in the industry.

What is the history and background of the company Huadong Medicine Co?

Huadong Medicine Co Ltd is a leading pharmaceutical company based in China. Established in 1993, the company has grown rapidly and gained prominence in the global market. With a focus on research, development, and production of high-quality drugs, Huadong Medicine Co Ltd has become a trusted name in the industry. The company specializes in areas such as chemical drugs, traditional Chinese medicine, and biological medicine. Over the years, Huadong Medicine Co Ltd has expanded its product portfolio and global reach through strategic partnerships and acquisitions. Known for its commitment to innovation and customer satisfaction, Huadong Medicine Co Ltd continues to thrive in the competitive pharmaceutical sector.

Who are the main competitors of Huadong Medicine Co in the market?

The main competitors of Huadong Medicine Co Ltd in the market include companies such as Shanghai Pharma, Shanghai Fosun Pharmaceutical Group, and Sinopharm Group. These companies also operate in the pharmaceutical industry and compete with Huadong Medicine Co Ltd in terms of product offerings, market share, and business expansion.

In which industries is Huadong Medicine Co primarily active?

Huadong Medicine Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Huadong Medicine Co?

The business model of Huadong Medicine Co Ltd focuses on the pharmaceutical industry. As a leading Chinese pharmaceutical company, Huadong Medicine is committed to research, development, production, and sales of innovative drugs and traditional Chinese medicines. The company operates across multiple segments including prescription drugs, over-the-counter drugs, and healthcare products. Huadong Medicine Co Ltd strives to enhance its market position through mergers and acquisitions, partnerships, and continuous investments in research and development. By maintaining a comprehensive product portfolio and a strong distribution network, the company aims to provide high-quality healthcare solutions to patients in China and globally.

What is the P/E ratio of Huadong Medicine Co 2025?

The Huadong Medicine Co P/E ratio is 18.38.

What is the P/S ratio of Huadong Medicine Co 2025?

The Huadong Medicine Co P/S ratio is 1.55.

What is the Quality Investing of Huadong Medicine Co?

The Quality Investing for Huadong Medicine Co is 10/10.

What is the revenue of Huadong Medicine Co 2025?

The expected Huadong Medicine Co revenue is 45.35 B CNY.

How high is the profit of Huadong Medicine Co 2025?

The expected Huadong Medicine Co profit is 3.82 B CNY.

What is the business model of Huadong Medicine Co

Huadong Medicine Co Ltd is an internationally operating company specialized in the field of pharmaceutical products. The company is organized into different divisions in order to optimally fulfill the individual requirements of customer groups. The company's divisions include a wide range of pharmaceutical active ingredients, products for animal health, production of raw materials for the cosmetics and food industry, as well as research and development services. The pharmaceutical active ingredients produced by Huadong Medicine serve as raw materials for the production of medications. The company offers a wide range of active ingredients used for the treatment of various diseases. In addition, Huadong Medicine also produces veterinary medicines for livestock and pets. The company's animal health division provides solutions for animal diseases and parasite management. With its commitment to sustainability and progressiveness, Huadong Medicine is also involved in the production of high-quality chemical raw materials for the cosmetics and food industry. Both the quality of the raw materials and environmental and climate protection are at the forefront. In addition to the mentioned divisions, Huadong Medicine also operates a research and development division focused on the discovery and development of new active ingredients. The company has focused on the development of innovative drugs for various indications. One particular strength of the company is its experience in the production of generic products, which are in increasing demand. By producing generics, the costs of manufacturing medications can be reduced, ultimately leading to lower prices for consumers. Huadong Medicine has made a name for itself in the Chinese pharmaceutical industry and is also internationally active. The company has several factories in China and also has branches in Europe, the USA, and Asia. Overall, Huadong Medicine Co Ltd has an extensive business model based on the needs of consumers and the pharmaceutical industry. The company specializes in the production of pharmaceutical active ingredients, veterinary medicines, chemical raw materials, research and development services, as well as generics. Huadong Medicine has earned a good reputation in the industry due to its comprehensive range of products and its commitment to sustainability and progressiveness.

What is the Huadong Medicine Co dividend?

Huadong Medicine Co pays a dividend of 0.29 CNY distributed over 1 payouts per year.

How often does Huadong Medicine Co pay dividends?

Huadong Medicine Co pays out a dividend 1 times a year.

What is the Huadong Medicine Co ISIN?

The ISIN of Huadong Medicine Co is CNE0000011S1.

What is the Huadong Medicine Co ticker?

The ticker of Huadong Medicine Co is 000963.SZ.

How much dividend does Huadong Medicine Co pay?

Over the past 12 months, Huadong Medicine Co paid a dividend of 0.93 CNY . This corresponds to a dividend yield of about 2.32 %. For the coming 12 months, Huadong Medicine Co is expected to pay a dividend of 1.03 CNY.

What is the dividend yield of Huadong Medicine Co?

The current dividend yield of Huadong Medicine Co is 2.32 %.

When does Huadong Medicine Co pay dividends?

Huadong Medicine Co pays a quarterly dividend. This is distributed in the months of July, June, October, July.

How secure is the dividend of Huadong Medicine Co?

Huadong Medicine Co paid dividends every year for the past 14 years.

What is the dividend of Huadong Medicine Co?

For the upcoming 12 months, dividends amounting to 1.03 CNY are expected. This corresponds to a dividend yield of 2.57 %.

In which sector is Huadong Medicine Co located?

Huadong Medicine Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Huadong Medicine Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Huadong Medicine Co from 6/5/2025 amounting to 0.58 CNY, you needed to have the stock in your portfolio before the ex-date on 6/5/2025.

When did Huadong Medicine Co pay the last dividend?

The last dividend was paid out on 6/5/2025.

What was the dividend of Huadong Medicine Co in the year 2024?

In the year 2024, Huadong Medicine Co distributed 0.29 CNY as dividends.

In which currency does Huadong Medicine Co pay out the dividend?

The dividends of Huadong Medicine Co are distributed in CNY.

All fundamentals about Huadong Medicine Co

Our stock analysis for Huadong Medicine Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Huadong Medicine Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.